The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Portfolio of GlaxoSmithKline plc consumer and OTC brands
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised GlaxoSmithKline plc, a leading British pharmaceutical company, on the disposal of a portfolio of consumer and OTC brands to Omega Pharma NV, a subsidiary of Perrigo Company plc
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Telecity Group plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Telecity Group plc, Europe’s leading provider of premium carrier-neutral data centres, on a recommended cash and share offer from Equinix, Inc. a leading US provider of colocation data centre services globally
![Japan Japan flag](https://www.greenhill.com/sites/default/files/japan.gif)
Hitachi Appliances, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Hitachi, LTD / Hitachi Appliances, Inc, a leading global industrial conglomerate focused on information and telecommunications systems, power systems and social systems, on their formation of a global HVAC joint venture with Johnson Controls
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
MannKind Corporation
![France France flag](https://www.greenhill.com/sites/default/files/france.gif)
Advised MannKind, a biopharmaceutical company focused on the development of therapeutic products for patients with diabetes, on a collaboration with Sanofi, comprising licensing, supply and loan facility agreements with respect to licensing the Company’s lead product AFREZZA. MannKind will receive up to $925 million in upfront and milestone payments plus 35% of future profits.
![USA/Germany U.S.A., Germany flags](https://www.greenhill.com/sites/default/files/usa_germany.gif)
Siemens Health Services
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Cerner Corporation, a leader in healthcare information services, on the acquisition of the assets of Siemens Aktiengesellschaft’s healthcare information technology business unit, Siemens Health Services, for $1.3 billion in cash.
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
Clinuvel Pharmaceuticals Limited
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Clinuvel, a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders, in response to an unsolicited proposal to acquire the business from Retrophin, a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Frank Russell Company
![United Kingdom United Kingdom flag](https://www.greenhill.com/sites/default/files/uk.gif)
Advised LSEG on the proposed acquisition of Frank Russell Company, the number one provider of benchmarks to US-focused equity funds and a leading provider of multi-asset class investment solutions, from Northwestern Mutual Life Insurance Company, including acting as Joint Sponsor to LSEG on its $1.6 billion rights issue
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
BancTec, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised BancTec, Inc., a leading business process outsourcing company, on its acquisition by HandsOn3, LLC and subsequent combination with Dataforce Group to create one of the largest pure-play BPO businesses, spanning over 50 countries
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Forest Laboratories Inc.
![Ireland Ireland flag](https://www.greenhill.com/sites/default/files/ireland.gif)
Advised Actavis plc, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products on its acquisition of Forest Laboratories Inc.
![Sweden Sweden flag](https://www.greenhill.com/sites/default/files/sweden.gif)
Unfors Raysafe AB
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised the Sixth Swedish National Pension Fund on the sale of Unfors Raysafe AB, a provider of easy-to-use products that help to reduce unnecessary radiation exposure, to Fluke Biomedical Corp., a subsidiary of Danaher Corp. that manufactures biomedical test and simulation products
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Fidelis SeniorCare Inc. (Michigan Heath Plan)
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Fidelis SeniorCare Inc., a healthcare provider focused on the care of the elderly, on the sale of a majority of its SecureCare Michigan health plan to Centene Corporation, a managed care provider focused on the Medicaid space
![Ireland Ireland flag](https://www.greenhill.com/sites/default/files/ireland.gif)
Warner Chilcott, plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
TNS, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised the Special Committee of the Board of Directors of TNS, Inc., a leading global provider of data communications and interoperability solutions, on its sale to Siris Capital Group, a private equity firm focused on complex, control equity investments in the telecom, technology and technology-enabled business service sectors
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
JDA Software
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised RedPrairie on the acquisition of JDA Software, a leading provider of supply chain management software
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Cymer, Inc.
![Netherlands Netherlands flag](https://www.greenhill.com/sites/default/files/niederland.gif)
Advised ASML Holding NV, a leading provider of lithography systems for the semiconductor industry, on its acquisition of Cymer, Inc., a leading supplier of lithography light sources used by chipmakers to manufacture advanced semiconductor devices
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Ramtron International Corporation
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Cypress Semiconductor Corporation, a leading provider of mixed-signal and programmable solutions worldwide, on its unsolicited acquisition of Ramtron International Corporation, a leading provider of ferroelectric random access memory (F-RAM) devices
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Deltek, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Deltek, Inc., the leading global provider of enterprise software and information solutions for professional services firms and government contractors, on its acquisition by Thoma Bravo, LLC
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Coventry Health Care Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Coventry Health Care Inc., a diversified managed health care company that offers a full portfolio of managed care products serving the commercial group and individual, Medicare Advantage, Medicare Part D and Medicaid markets, on its acquisition by Aetna
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Alpine Access, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised SYKES Enterprises, a leading global provider of outsourced customer contact management solutions and services, on its acquisition of Alpine Access, a leader in at-Home customer contact management solutions and services
![Netherlands Netherlands flag](https://www.greenhill.com/sites/default/files/niederland.gif)
ASML Holding NV (minority stake)
![USA/Taiwan/SKorea U.S.A., Taiwan, South Korea flags](https://www.greenhill.com/sites/default/files/us-taiwan-skorea_49129.gif)
Advised the Supervisory Board of ASML on the establishment of a Customer Co-Investment Program including the issue of 23% equity stake and $1.7 billion of R&D funding
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
ISTA Pharmaceuticals, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its sale to Bausch + Lomb, Inc., a global ophthalmic products company
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
ISTA Pharmaceuticals, Inc.
Advised ISTA Pharmaceuticals, an ophthalmic pharmaceutical company, on its defense against an unsolicited offer from Valeant Pharmaceuticals and on its review of strategic alternatives
![Australia Australia flag](https://www.greenhill.com/sites/default/files/australia.gif)
iNova Pharmaceuticals
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Archer Capital and Ironbridge Capital on the sale of iNova Pharmaceuticals, a leading pharmaceuticals company that sells and distributes a range of prescription and over-the-counter products in Australia, New Zealand, Asia and Southern Africa, to Valeant Pharmaceuticals
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
American Dental Partners, Inc.
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised American Dental Partners, Inc. (NASD: ADPI), one of the nation’s leading business partners to dental group practices, on its sale to JLL Partners, a leading private equity firm
![Japan Japan flag](https://www.greenhill.com/sites/default/files/japan.gif)
Diabetes-related patent estate and royalty stream of Astellas Pharma subsidiary, Prosidion
![United States United States flag](https://www.greenhill.com/sites/default/files/usa_0.gif)
Advised Royalty Pharma, a leading acquiror of biopharmaceutical royalty interests, on the acquisition of the DPP-IV patent estate and associated royalty stream of Astellas Pharma subsidiary, Prosidion